Steve Munoz
Overview
Explore the profile of Steve Munoz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma R, Williams P, Gupta A, McCluskey B, Bhaskaran S, Munoz S, et al.
Oncotarget
. 2015 May;
6(25):21589-602.
PMID: 26009993
Treatment of multiple myeloma with bortezomib can result in severe adverse effects, necessitating the development of targeted inhibitors of the proteasome. We show that stable expression of a dominant-negative F-box...
2.
Nyman J, Munoz S, Jadhav S, Mansour A, Yoshii T, Mundy G, et al.
J Biomech
. 2009 Mar;
42(7):891-7.
PMID: 19281987
Although fracture healing is frequently studied in pre-clinical models of long bone fractures using rodents, there is a dearth of objective quantitative techniques to assess successful healing. Biomechanical testing is...
3.
Oyajobi B, Garrett I, Gupta A, Flores A, Esparza J, Munoz S, et al.
Br J Haematol
. 2007 Oct;
139(3):434-8.
PMID: 17910634
Impaired bone formation contributes to the lack of bone healing in multiple myeloma and there is a need for agents with bone anabolic properties to reverse the bone deficit in...
4.
Oyajobi B, Munoz S, Kakonen R, Williams P, Gupta A, Wideman C, et al.
Mol Cancer Ther
. 2007 Jun;
6(6):1701-8.
PMID: 17541032
Development of new therapies for myeloma has been hindered by the lack of suitable preclinical animal models of the disease in which widespread tumor foci in the skeleton can be...
5.
Oyajobi B, Franchin G, Williams P, Pulkrabek D, Gupta A, Munoz S, et al.
Blood
. 2003 Mar;
102(1):311-9.
PMID: 12649140
Recent data have implicated macrophage inflammatory protein-1alpha (MIP-1alpha) in multiple myeloma (MM)-associated osteolysis. However, it is unclear whether the chemokine's effects are direct, to enhance osteolysis, or indirect and mediated...